Amsterdam’s life sciences and pharma sectors are booming
Pharmaceutical giant Sanofi has opened a new European office in Amsterdam. Around 500 employees – 200 from Sanofi’s Gouda offices and 300 from the European headquarters of Sanofi Genzyme, previously located in Naarden – have moved to the Amsterdam Health & Technology Center (AHTC), a hub for biotech, e-health and pharmaceutical companies near Amsterdam UMC. Sanofi is one of the largest pharmaceutical companies in the world, earning €35billion in revenue in 2017. It is one of the numerous life sciences and health companies that have moved to Amsterdam in 2018, many of which took the step after the European Medicines Agency (EMA) announced its move to Amsterdam from London.
A new life sciences district for Amsterdam
The AHTC is located in Amsterdam’s Zuidoost neighbourhood, on the edge of the Zuidas business district. The area is currently being developed into an ‘Amsterdam Life Sciences District’, further strengthening Amsterdam’s status as an innovation hub where research and business come together to work on new technologies and medicines. Sanofi’s Managing Director Bert de Jong says: “Sanofi feels right at home in Amsterdam, close to important partners from the health sector. Amsterdam’s innovative character is a great fit for Sanofi as an international developer of ground-breaking medicines and vaccines.”
European Medicines Agency
The new office is just a short distance from the EMA’s future base. While Sanofi’s choice for Amsterdam had been made before the announcement of the EMA’s move to the city, the news was received with great joy by the firm, De Jong told De Telegraaf. “The EMA’s arrival makes it even more of a logical step that we are moving here.” He added that the EMA’s arrival had made the country more attractive for businesses from the sector, saying that colleagues from other large internationals were already asking him questions about settling in Amsterdam.